Information Provided By:
Fly News Breaks for May 6, 2019
PODD
May 6, 2019 | 06:23 EDT
BTIG analyst Sean Lavin upgraded Insulet to Buy with a price target of $115 after its "stellar" Q1 results and "upbeat" discussion of factors contributing to rising patient demand. The analyst contends that the next several quarters will bring more catalyst opportunities through pharmacy access, high interest in DASH, a no-commitment payment model, and "two shots on goal" for automated insulin delivery with Horizon and Loop. Lavin also sees Insulet as "somewhat protected" from the competition given its patch pump niche.
News For PODD From the Last 2 Days
There are no results for your query PODD